Hemostatic and toxinological diversities in venom of Micrurus tener tener, Micrurus fulvius fulvius and Micrurus isozonus coral snakes

Toxicon

Volumn 58, Issue 1, 2011, Pages 35-45

  Salazar, Ana M ^a   Vivas, Jeilyn ^a   Sánchez, Elda E ^b   Rodríguez Acosta, Alexis ^c,d   Ibarra, Carlos ^a   Gil, Amparo ^a   Carvajal, Zoila ^a   Girón, María E ^c,d   Estrella, Amalid ^c,d   Navarrete, Luis F ^c   Guerrero, Belsy ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Coral snakes; Fibrino(geno)lytic activity; Hemostasis; Micrurus tener tener; Plasmin inhibitors; Platelets; Venom

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRINOGEN; MICRURUS FULVIUS FULVIUS VENOM; MICRURUS TENER TENER VENOM; PLASMIN; SNAKE VENOM; THROMBIN; UNCLASSIFIED DRUG; VENOM;

ANIMAL EXPERIMENT; ARTICLE; BIOGEOGRAPHIC REGION; BIOLOGICAL ACTIVITY; BLOOD CLOTTING; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FIBRINOLYSIS; GEOGRAPHICAL VARIATION (SPECIES); HEMOSTASIS; HUMAN; LD 50; MICRURUS FULVIUS FULVIUS; MICRURUS ISOZONUS; MICRURUS TENER TENER; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; SNAKE; THROMBOCYTE AGGREGATION INHIBITION; UNITED STATES; VENEZUELA;

ANIMALS; BLOOD COAGULATION; ELAPID VENOMS; ELAPIDAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBRINOLYTIC AGENTS; HEMOSTATICS; HUMANS; LETHAL DOSE 50; MICE; MICE, INBRED BALB C; PLASMA; PLATELET AGGREGATION; SPECIES SPECIFICITY;

ELAPIDAE; FULVIUS; LONCHOCARPUS GLAUCIFOLIUS; MICRURUS; MICRURUS FULVIUS FULVIUS;

EID: 79959379509     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.04.020     Document Type: Article

References (69)

1. Aguilar I., Girón M.E., Rodríguez-Acosta A. Purification and characterization of a hemorrhagic fraction from the venom of the Uracoan rattlesnake Crotalus vegrandis. Biochim. Byophys. Acta 2001, 1548:57-65.
2. Aird S.D., da Silva N.J. Comparative enzymatic composition of Brazilian coral snake (Micrurus) venoms. Comp. Biochem. Physiol. B. 1991, 99:287-294.
3. Alape-Girón A., Lomonte B., Gustafsson B., Da Silva N.J., Thelestam M. Electrophoretic and immunochemical studies of Micrurus snake venoms. Toxicon 1994, 32:713-723.
4. Alape-Girón A., Persson B., Cederlund E., Flores-Díaz M., Gutiérrez J.M., Thelestam M., Bergman T., Jörnvall H. Elapid venom toxins: multiple recruitments of ancient scaffolds. Eur. J. Biochem. 1999, 225-234.
5. Arce V., Rojas E., Ownby C.L., Rojas G., Gutiérrez J.M. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Toxicon 2003, 41:851-860.
6. Banerjee Y., Mizuguchi J., Iwanaga S., Kini M. Hemextin AB complex - A snake venom anticoagulant protein complex that inhibits factor VIIa activity. Pathophysiol. Haemost. Thromb. 2005, 34:184-187.
7. Barros A.C.S., Fernandes D.P., Ferreira L.C.L., Santos M.C. Local effects induced by venoms from five species of genus Micrurus sp. (coral snakes). Toxicon 1994, 32:445-452.
8. Bjarnason J.B., Fox J.W. Hemorrhagic metalloproteinases from snake venoms. Pharmacol. Ther. 1994, 62:325-372.
9. Braud S., Bon C., Wisner A. Snake venom proteins acting on hemostasis. Biochimie 2000, 82:851-859.
10. Cecchini A.L., Marcussi S., Silveira L.B., Borja-Oliveira C.R., Rodrigues-Simioni L., Amara S., Stabeli R.G., Giglio J.R., Arantes E.C., Soares A.M. Biological and enzymatic activities of Micrurus sp. (Coral) snake venoms. Comp. Biochem. Physiol. Part A 2005, 140:125-134.
11. Chester A., Crawford G.P. In vitro coagulant properties of venoms from Australian snakes. Toxicon 1982, 20:501-504.
12. Cho I.H., Choi E.S., Lim H.G., Lee H.H. Purification and characterization of six fibrinolytic serine-proteases from earthworm Lumbricus rubellus.J. Biochem. Mol. Biol. 2004, 37:199-205.
13. Daoud E., Tu A.T., el-Asmar M.F. Isolation and characterization of an anticoagulant proteinase, cerastase F-4, from Cerastes cerastes (Egyptian sand viper) venom. Thromb. Res. 1986, 42:55-62.
14. de Roodt A.R., Paniagua-Solis J.F., Dolab J.A., Estévez-Ramiréz J., Ramos-Cerrillo B., Litwin S., Dokmetjian J.C., Alagón A. Effectiveness of two common antivenoms for North, central, and south American Micrurus envenomations. J. Toxicol. Clin. Toxicol. 2004, 42:171-178.
15. Dokmetjian J.C., Del Canto S., Vinzón S., de Jiménez-Bonino M.B. Biochemical characterization of the Micrurus pyrrhocryptus venom. Toxicon 2009, 53:375-382.
16. Fabre J.E., Gurney M.E. Limitations of current therapies to prevent thrombosis: a need for novel strategies. Mol. Biosyst. 2010, 6:305-315.
17. Francis B.R., da Silva, Júnior N.J., Seebart C., Casais E., Silva L.L., Schmidt J.J., Kaiser I.I. Toxins isolated from the venom of the Brazilian coral snake (Micrurus frontalis frontalis) include hemorrhagic type phospholipases A2 and postsynaptic neurotoxins. Toxicon 1997, 35:1193-1203.
18. Fry B.G. Structure-function properties of venom components from Australian elapids. Toxicon 1999, 37:11-32.
19. Gerads I., Tans G., Yukelson LYa., Zwaal R.F., Rosing J. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana. Toxicon 1992, 30:1065-1079.
20. Gowda C.D., Nataraju A., Rajesh R., Dhananjaya B.L., Sharath B.K., Vishwanath B.S. Differential action of proteases from Trimeresurus malabaricus, Naja naja and Daboia russellii venoms on hemostasis. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 2006, 143:295-302.
21. Gutiérrez J.M., Lomonte B., Portilla E., Cerdas L., Rojas E. Local effects induced by coral snake venoms: evidence of myonecrosis after experimental inoculations of venoms from five species. Toxicon 1983, 21:777-783.
22. Gutiérrez J.M., Rojas G., Pérez A., Argüello I., Lomonte B. Neutralization of coral snake Micrurus nigrocinctus venom by a monovalent antivenom. Braz. J. Med. Biol. Res. 1991, 24:701-710.
23. Gutiérrez J.M., Rojas G., da Silva Júnior N.J., Núñez J. Experimental myonecrosis induced by the venoms of South American Micrurus (coral snakes). Toxicon 1992, 30:1299-1302.
24. Guerrero B., Arocha-Piñango C.L. Activation of human prothrombin by the venom of Lonomia achelous (Cramer) caterpillars. Thromb. Res. 1992, 66:169-177.
25. Jagadeesha D.K., Shashidhara-Murthy R., Girish K.S., Kemparaju K. A non-toxic anticoagulant metalloprotease: purification and characterization from Indian cobra (Naja naja naja) venom. Toxicon 2002, 40:667-675.
26. Kamiguti A.S., Hay C.R.M., Theakston R.D.G., Zuzel M. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 1996, 34:627-642.
27. Kerns R.T., Kini R.M., Stefansson S., Evans H.J. Targeting of venom phospholipases: the strongly anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex. Arch. Biochem. Biophys. 1999, 369:107-113.
28. Kini R.M., Evans H.J. Inhibition of platelet aggregation by a fibrinogenases from Naja nigricollis venom is independent of fibrinogen degradation. Biochim. Biophys. Acta 1991, 1095:117-121.
29. Kini R.M., Evans H.J. Structural domains in venom proteins: evidence that metalloproteinases and non-enzymatic platelet aggregation inhibitors (Disintegrins) from the snake venoms are derived by proteolysis from a common precursor. Toxicon 1992, 30:265-293.
30. Kini R.M. Serine proteases affecting blood coagulation and fibrinolysis from snake venoms. Pathophysiol. Haemost. Thromb. 2005, 34:200-204.
31. Kumar M.S., Devaraj V.R., Vishwanath B.S., Kemparaju K. Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra (Naja naja) venom. J. Thromb. Thrombolysis 2010, 29:340-348.
32. Lowry O.H., Rosembrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 1193:265-275.
33. Markland F.S. Snake Venoms and the Hemostatic System. Toxicon 1998, 36:1749-1800.
34. Marsh N.A., Arocha-Piñango C.L. Evaluation of the fibrin plate method for estimating plasminogen activators. Thromb. Diath. Haemorrh 1972, 28:75-88.
35. Maruyama M., Suzuki M., Yoshida E., Mihara H., Nakajima N. Purification and characterization of two fibrinolytic enzymes from Bothrops jararaca (Jararaca) venom. Toxicon 1992, 30:853-864.
36. Masci P.P., Whitaker A.N., Sparrow L.G., de Jersey J., Winzor D.J., Watters D.J., Lavin M.F., Gaffney P.J. Textilinins from Pseudonaja textilis textilis. Characterization of two plasmin inhibitors that reduce bleeding in an animal model. Blood. Coagul. Fibrinolysis 2000, 385-393.
37. Matsui T., Fujimura Y., Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim. Biophys. Acta 2000, 1477:146-156.
38. Millers E.K., Trabi M., Masci P.P., Lavin M.F., de Jersey J., Guddat L.W. Crystal structure of textilinin-1, a Kunitz-type serine protease inhibitor from the venom of the Australian common brown snake (Pseudonaja textilis). FEBS J. 2009, 276:3163-3175.
39. Moran J.B., Geren C.R. Characterization of a fibrinogenase from northern copperhead (Agkistrodon contortrix mokasen) venom. Biochim. Biophys. Acta 1981, 659:161-168.
40. Principles of Laboratory Animal Care 1985, vol. 85. NIH., National Institute of Health, USA, 1-112.
41. Nishida S., Fujimura Y., Miura S., Ozaki Y., Usami Y., Suzuki S., Titán K., Yoshida E., Sugimoto M., Yoshioka A., Fukui H. Purification and characterization of bothrombin, a fibrinogen-clotting serine protease from the venom of Bothrops jararaca. Biochemistry 1994, 33:1843-1849.
42. Osipov A.V., Filkin S.Y., Makarova Y.V., Tsetlin V.I., Utkin Y.N. A new type of thrombin inhibitor, noncytotoxic phospholipase A2, from the Naja naje cobra venom. Toxicon 2010, 186-194.
43. Oyama E., Takahashi H. Distribution of low molecular weight platelet aggregation inhibitors from snake venoms. Toxicon 2007, 49:293-298.
44. Rao V.S., Swarup S., Kini R.M. The non-enzymatic subunit of pseutarin C, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom, shows structural similarity to mammalian coagulation factor V. Blood 2003, 102:1347-1354.
45. Rengifo C., Rodríguez-Acosta A. Serpientes, venenos y su tratamiento en Venezuela 2004, Fondo de Publicaciones de la Facultad de Medicina de la Universidad Central de Venezuela, Caracas, 1-86. 1er ed.
46. Ritonja A., Turk V., Gubensek F. Serine proteinase inhibitors from Vipera ammodytes venom. Isolation and kinetic studies. Eur. J. Biochem. 1983, 133:427-432.
47. Rosso J.P., Vargas-Rosso O., Gutiérrez J.M., Rochat H., Bougis P.E. Characterization of alpha-neurotoxin and phospholipase A2 activities from Micrurus venoms. Determination of the amino acid sequence and receptor-binding ability of the major alpha-neurotoxin from Micrurus nigrocinctus nigrocinctus. Eur. J. Biochem. 1996, 238:231-239.
48. Roze J.A. Coral Snakes of the Americas: Biology, Identification, and Venoms 1996, Krieger Publishing Company, Malabar, pp. 1-340.
49. Sakurai Y., Takatsuka H., Yoshioka A., Matsui T., Suzuki M., Titani K., Fujimura Y. Inhibition of human platelet aggregation by L-amino acid oxidase purified from Naja naja kaouthia venom. Toxicon 2001, 39:1827-1833.
50. Salazar A.M., Rodríguez-Acosta A., Girón M.E., Aguilar I., Guerrero B. A comparative analysis of the clotting and fibrinolytic activities of the mapanare (Bothrops atrox) snake venom from different geographical areas in Venezuela. Thromb. Res. 2007, 120:95-104.
51. Sánchez E.E., Lopez-Johnston J.C., Rodríguez-Acosta A., Pérez J.C. Neutralization of two North American coral snake venoms with United States and Mexican antivenoms. Toxicon 2008, 51:297-303.
52. Satish S., Tejaswini J., Krishnakantha T.P., Gowda T.V. Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom. Biochimie 2004, 86:203-210.
53. Stefansson S., Kini R.M., Evans H.J. The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 1990, 29:7742-7746.
54. St Pierre L., Masci P.P., Filippovich I., Sorokina N., Marsh N., Miller D.J., Lavin M.F. Comparative analysis of prothrombin activators from the venom of Australian elapids. Mol. Biol. Evol. 2005, 22:1853-1864.
55. Stoscheck C.M. Quantitation of protein. Methods Enzymol. 1990, 182:50-68.
56. Sundell I.B., Rånby M., Zuzel M., Robinson K.A., Theakston R.D. In vitro procoagulant and anticoagulant properties of Naja naja naja venom. Toxicon 2003, 42:239-247.
57. Suntravat M., Nuchprayoon I., Pérez J.C. Comparative study of anticoagulant and procoagulant properties.f 28 snake venoms from families Elapidae, Viperidae, and purified Russell's viper venom-factor X activator (RVV-X). Toxicon 2010, 56:544-553.
58. Swenson S., Markland F.S. Snake venom fibrin(ogen)olytic enzymes. Toxicon 2005, 45:1021-1039.
59. Takahashi H., Iwanaga S., Kitagawa T., Hokama Y., Suzki T. Snake venom proteinase inhibitors. Chemical structure of inhibitor II isolated from the venom of Russell's viper (Viper russelli). J. Biochem. 1974, 76:721-733.
60. Tanaka G.D., Furtado M.F., Portaro F.C., Sant'Anna O.A., Tambourgi D.V. Diversity of Micrurus snake species related to their venom toxic effects and the prospective of antivenom neutralization. PLoS Negl Trop. Dis. 2010, 4:e622.
61. Urdaneta A.H., Bolaños F., Gutiérrez J.M. Feeding behavior and venom toxicity of coral snake Micrurus nigrocinctus (Serpentes: Elapidae) on its natural prey in captivity. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2004, 138:485-492.
62. Utkin Y.N., Osipov A.V. Non-Lethal Polypeptide components in cobra venom. Current. Pharmaceutical. Design 2007, 13:2906-2915.
63. Varon D., Shai E., Spectre G. Frontiers in platelet inhibition. Discov. Med. 2009, 8:242-246.
64. White J. Snake venoms and coagulopathy. Toxicon 2005, 45:951-967.
65. Wijeyewickrema L.C., Gardiner E.E., Shen Y., Berndt M.C., Andrews R.K. Fractionation of snake venom metalloproteinases by metal ion affinity: a purified cobra metalloproteinase, Nk, from Naja kaouthia binds Ni2+-agarose. Toxicon 2007, 50:1064-1072.
66. Progress in the Characterization of Venoms and Standardization of Antivenoms 1981, World Health Organization, WHO Offset Publication 58, Geneva.
67. Zaganelli G.L., Zaganelli M.G.M., Magalhaes A., Diniz C.R., de Lima M.E. Purification and characterization of fibrinogenase from the venom of Jararacucu (Bothrops jararacussu). Toxicon 1996, 34:807-819.
68. Zhang Y., Wisner A., Xiong Y., Bon C. A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning. J. Biol. Chem. 1995, 270:10246-10255.
69. Zingali R.B., Jandrot-Perrus M., Guillén M.C., Bon C. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry 1993, 32:10794-10802.